FTC halts case against CVS Caremark, OptumRx

By Axios
| April 03, 2025

The FTC issued the stay in the case against CVS Caremark, OptumRx and Express Scripts in response to a motion "citing the fact that there are currently no sitting Commissioners able to participate in this matter."

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...